Special Products Limited, the specialty pharmaceutical company focused on niche therapeutic areas, is pleased to announce that Chris Grimes, a highly experienced commercial manager in the pharmaceutical industry, has been appointed as Director.
Chris, who joined Special Products Limited in July 2013, will also join the company’s Board of Directors. Chris will provide commercial oversight and strategic guidance to support the future growth of the company. Chris has gained vast experience managing and launching pharmaceutical products within global markets and delivering technology transfer projects on multiple product ranges.
Special Products’ Chairman, Graham March, commented: “I am delighted to welcome Chris Grimes to our Board of Directors. His breadth of commercial experience has been clearly evident since he joined Special Products Limited in 2013 and I look forward to his continued contribution to the company in his new role.”